Automação e validação do método de oxidação do NADPH para a mensuração da atividade da glutationa redutase: determinação dos limites de referência e avaliação da influência da lipemia, hemoglobina e bilirrubina

• Ano de defesa: 2013
• Autor(a) principal: Hermes, Carine Lima
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Santa Maria; BR; Farmácia; UFSM; Programa de Pós-Graduação em Ciências Farmacêuticas
• Palavras-chave em Português: Método automatizado; Validação; Glutationa redutase; Limites de referência; Interferência pré-analítica; Lipemia; Hemoglobina; Bilirrubina; Automated method; Validation; Glutathione reductase; Reference limits; Pre-analytical interference; Hemoglobin; Bilirubin; CNPQ::CIENCIAS DA SAUDE::FARMACIA
• Link de acesso: http://repositorio.ufsm.br/handle/1/6021

Glutathione (γ-L-glutamyl-L-cysteinylglycine) is the major non-protein thiol body and is involved in cellular antioxidant defense. The free glutathione is present mainly in its reduced form (GSH) and can be converted to the oxidized form (GSSG) in the presence of reactive oxygen species (ROS). The GSH/GSSG ratio high is very important for the cellular redox state and a reduction of this ratio is often used as an indicator of oxidative stress. The enzyme glutathione reductase (GR) catalyzes the reduction of GSSG to GSH using NADPH. Because of the great importance of the antioxidant glutathione and considering that it is present in almost all organisms, numerous studies involving several attempts to detect GSH, GSSG and GR in biological systems has been performed. The objective of this study was to validate an automated analytical method, based on a spectrophotometric method proposed by Mannervick and Carlberg in 1985 to measurement the GR activity which is the oxidation of NADPH, which is monitored spectrophotometrically at a wavelength of 340 nm using the automated analyzer Cobas Mira®, determine its limits of reference for a healthy population and further evaluate the pre-analytical interference that influence the analytical phase of hemoglobin, bilirubin and lipemia. The automated method for measuring of the GR activity was validated as recommended by the EMEA and ANVISA. Since it was linear (r2 = 0.990), precise, with a coefficient of variation (CV) in precision intraassay of 5.7% (50 U/L) and 3.4% (100 U/L) and precision interassay CV of 9.5% (50 U/L) and 9.9% (100 U/L). In addition, we observed a recovery of 114.1% with this method considered accurate. The reference limits were evaluated as recommended by the International Federation of Clinical Chemistry (IFCC), and were 21.7 U / L to 60.3 U / L, for a healthy population. In the simulation of hemolysis, lipemia and jaundice in plasma samples, we evaluated the pre-analytical interference in the activity of the GR. All concentrations of Intralipid® (0.67, 1.25, 2.5, 5 and 10 mg / dL), hemoglobin standard (0.0625, 0.125, 0.25, 0.5 and 1 g / dL), and bilirubin (0.9, 1.9, 3.8, 7.5, 15 and 30 mg / dL) resulted in a difference from the original value of GR, and verified a percentage greater than 5%, and this percentage considered for enzymes, analytical interference. Thus, it was concluded that the automated method developed was linear, precise, accurate, simple and inexpensive, and can be adapted to the Cobas Mira® analyzer. The reference limits for a healthy population were established. Furthermore, it was demonstrated that hemoglobin, lipemia and bilirubin interfere in the measurement of the GR activity.